Glial cells in amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease.
• Mutations in superoxide dismutase 1 (SOD1) cause 2% of ALS cases via toxic mutant protein properties.
• Non-neuronal cells influence neurodegeneration in ALS through non-cell autonomous mechanisms.

Purpose of the Study:

• To review the role of glial cell types in ALS pathology.
• To examine the contribution of astrocytes and microglia to neurodegeneration.
• To highlight the potential of glial cell-targeted therapies for ALS.

Main Methods:

• Review of studies on rodent models of ALS.
• Analysis of data from human ALS patients.
• Investigation of glial cell functions and damage in ALS.

Main Results:

• Astrogliosis and microgliosis are key hallmarks of ALS.
• Microglial activation intensity correlates with motor neuron damage severity in human ALS.
• Impaired astrocytic functions (glutamate clearance, neurotrophic factor release) and damage to astrocytes/microglia accelerate ALS progression.

Conclusions:

• Glial cells play an active and critical role in ALS pathogenesis.
• Understanding glial cell contributions is vital for sporadic ALS research.
• Therapies targeting glial cells hold potential for treating ALS.